Role of nitric oxide in recombinant tumor necrosis factor-α-induced circulatory shock: A study in patients treated for cancer with isolated limb perfusion

Critical Care Medicine

Volumn 24, Issue 11, 1996, Pages 1806-1810

  Zwaveling, Jan H ^a   Maring, Jan K ^a   Moshage, Han ^a   Van Ginkel, Robert J ^a   Hoekstra, Harald J ^a   Schraffordt Koops, Heimen ^a   Donse, Irene F ^a   Girbes, Armand R J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

critical illness; interleukin 1; isolated limb perfusion; nitrate; nitric oxide; nitrite; sepsis; sepsis syndrome; septic shock; tumor necrosis factor ; vasodilation

Indexed keywords

INTERLEUKIN 1; MELPHALAN; NITRIC OXIDE; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ADVANCED CANCER; ARTICLE; CANCER; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; CRITICAL ILLNESS; HISTIOCYTOMA; HUMAN; HYPOTENSION; LIMB PERFUSION; LIPOSARCOMA; MELANOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPTIC SHOCK; SYNOVIAL SARCOMA;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; EXTREMITIES; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MELPHALAN; MIDDLE AGED; NEOPLASMS; NITRATES; NITRIC OXIDE; NITRITES; SEPSIS; SHOCK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029804039     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199611000-00008     Document Type: Article

References (28)

1. Zwaveling JH, Maring JK, Clarke FL, et al: High plasma tumor necrosis factor (TNF)-α concentrations and a sepsis-like syndrome in patients undergoing hyperthermic isolated limb perfusion with recombinant TNF-α, interferon-γ, and melphalan. Crit Care Med 1996; 24: 765-770
2. Eggimann P, Chioléro R, Chassot PG, et al: Systemic and hemodynamic effects of recombinant tumor necrosis factor alpha in isolation perfusion of the limbs. Chest 1995; 107:1074-1082
3. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87:3629-3632
4. Creech O, Krementz ET: Cancer chemotherapy by perfusion. Adv Cancer Res 1968; 6:111-147
5. Hoekstra HJ, Naujocks T, Schraffordt Koops H, et al: Continuous leakage monitoring during hyperthermic isolated regional perfusion of the lower limb: Techniques and results. Regional Cancer Treatment 1992; 4:301-304
6. Moshage H, Kok B, Huizenga JR, et al: Nitrite and nitrate determinations in plasma: A critical evaluation. Clin Chem 1995; 41:892-896
7. 15N] nitrate in biological fluids. Anal Biochem 1982; 126:131-138
8. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012
9. Beasley D, Schwartz JH, Brenner BM: Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J Clin Invest 1991; 87:602-608
10. Cunha FQ, Assreuy J, Moss DW, et al: Differential induction of nitric oxide synthase in various organs of the mouse during endotoxemia: Role of tumor necrosis factor α and IL-1β. Immunology 1994; 81:211-215
11. Beasley D, McGuiggin M: Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J Exp Med 1994; 179:71-80
12. Gómez-Jiménez J, Salgado A, Mourelle M, et al: L-arginine: Nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med 1995; 23:253-258
13. Evans T, Carpenter A, Kidderman H, et al: Evidence of increased nitric oxide production in patients with the sepsis syndrome. Circ Shock 1993; 41:77-81
14. Petros A, Bennett D, Vallance P: Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558
15. Miles D, Thomsen L, Balkwill F, et al: Association between biosynthesis of nitric oxide and changes in immunological and vascular parameters in patients treated with interleukin-2. Eur J Clin Invest 1994; 24:287-290
16. Ochoa JB, Udekwu AO, Billiar TR, et al: Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 24:621-626
17. Jacob TD, Ochoa JB, Udekwu AO, et al: Nitric oxide production is inhibited in trauma patients. J Trauma 1993; 35: 590-597
18. Neilly IJ, Copland M, Haj M, et al: Plasma nitrate concentrations in neutropenic and non-neutropenic patients with suspected septicaemia. Br J Haematol 1995; 89:199-202
19. Guarner C, Soriano G, Tomas A, et al: Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia. Hepatology 1993; 18:1139-1143
20. Nava E, Palmer RMJ, Moncada S: Inhibition of nitric oxide synthesis in septic shock; how much is beneficial? Lancet 1991; 338:1555-1557
21. Palmer RMJ: The discovery of nitric oxide in the vessel wall. A unifying concept in the pathogenesis of sepsis. Arch Surg 1993; 128:396-401
22. ω-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992; 176:1175-1182
23. Wright CE, Rees DD, Moncada S: Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992; 26:48-57
24. Meyer J, Lentz CW, Stothert JC, et al: Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 1994; 22:306-312
25. 2 formation is increased in human sepsis syndrome. Effects of cyclooxygenase inhibition. Am Rev Respir Dis 1991; 144: 1095-1101
26. Joyce CD, Fiscus RR, Wang X, et al: Calcitonin gene-related peptide levels are elevated in patients with sepsis. Surgery 1990; 108:1097-1101
27. + channel mediates hypotension in endotoxemia and hypoxic lactic acidosis in dog. J Clin Invest 1992; 89: 2071-2074
28. 2+ channels in smooth muscle cells. Am J Physiol 1989; 257:C875-C881